Dupilumab's impact on nasal citology: Real life experience after 1 year of treatment
Open Access
- 29 March 2024
- journal article
- research article
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 45 (4) , 104275
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Eosinophil-mast cell pattern of intraepithelial infiltration as a marker of severity in CRSwNPScientific Reports, 2023
- Two‐year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 monthsAllergy, 2023
- The Role of Biologics in the Treatment of Chronic RhinosinusitisBioDrugs, 2023
- Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision makingExpert Review of Clinical Immunology, 2023
- Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real‐life study (DUPIREAL)Allergy, 2023
- Eosinophils: Focus on DNA extracellular trapsLife Sciences, 2022
- Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal PolypsThe Journal of Allergy and Clinical Immunology: In Practice, 2022
- Dupilumab-Associated Adverse Events During Treatment of Allergic DiseasesClinical Reviews in Allergy & Immunology, 2022
- The Healing Power of NeutrophilsTrends in Immunology, 2019
- Saline nasal irrigation for acute upper respiratory tract infections2010